Authors
Loading...
Randomized trial investigates pathobiologic differences and outcomes in hereditary breast cancer linked to BRCA1 and BRCA2, suggesting significant implications for patient care.
Marcus et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: